ClearPoint Neuro, Inc. (CLPT)

↓ Download CSV

CIK 0001285550 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, ClearPoint Neuro, Inc. reported revenue of $36.97M, up 17.8% from the prior year. The company ran a net loss, with a net margin of -69.1% and a gross margin of 61.4%. It held $97.75M in total assets against $69.73M in total liabilities.

Key ratios (FY2025)

61.4%
Gross margin
-65.4%
Operating margin
-69.1%
Net margin
-91.1%
Return on equity
+17.8%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$36.97M$31.39M$23.95M$20.55M$16.30M$12.83M$11.22M$7.35M$7.38M$5.75M
Cost of Revenue$14.28M$12.27M$10.34M$7.02M$5.18M$3.71M$3.94M$2.43M$2.90M
Gross Profit$22.69M$19.12M$13.61M$13.53M$11.12M$9.12M
Operating Income-$24.16M-$19.73M-$22.45M-$16.33M-$13.37M-$6.22M-$4.59M-$5.25M-$6.34M-$7.49M
Net Income-$25.54M-$18.91M-$22.09M-$16.43M-$14.41M-$6.78M-$5.54M-$6.16M-$7.17M-$8.07M
EPS (Diluted)$-0.90$-0.70$-0.90$-0.68$-0.69
Total Assets$97.75M$39.19M$42.66M$55.49M$65.58M$29.52M$11.93M$7.86M$13.90M$7.40M
Total Liabilities$69.73M$13.80M$21.49M$18.60M$16.79M$27.14M$7.34M$6.35M$8.07M$8.16M
Shareholders' Equity$28.02M$25.39M$21.17M$36.89M$48.79M$2.38M$4.59M$1.51M$5.83M-$756.1K
Cash & Equivalents$45.92M$20.10M$23.14M$27.61M$54.11M$20.10M$5.70M$3.10M$9.29M$3.32M
Operating Cash Flow-$23.93M-$8.95M-$13.72M-$16.17M-$12.70M-$7.81M-$2.85M-$4.63M-$5.99M-$5.82M
Capital Expenditures$522.0K$275.0K$717.0K$253.0K$168.0K$41.0K$10.0K$63.5K$26.8K$101.0K
Shares Outstanding29.37M27.62M24.65M24.58M23.67M17.05M15.24M11.02M10.69M3.62M